PUBLICACIÓN

Pre-launch activities by generic companies: patent law and unfair competition

icon 15 de marzo, 2013
Background
The defendant had obtained marketing authorisations for the commercialisation of its drugs more than three years before the expiry date of the supplementary protection certificate (SPC) protecting the relevant active ingredient. The defendant not only obtained these marketing authorisations, but also applied for and obtained price fixation for its drugs and requested their inclusion in the National Health System.

icon

Descargar documento

Tipología

Análisis

Contacto para prensa

Sandra Cuesta
Sandra Cuesta
Directora de Desarrollo de Negocio, Marketing y Comunicación
Sandra Cuesta
Sandra Cuesta
Directora de Desarrollo de Negocio, Marketing y Comunicación
icon
icon

Más información sobre
Gómez-Acebo & Pombo

icon
icon
icon
icon